{"id":3631,"date":"2026-02-02T08:08:04","date_gmt":"2026-02-02T07:08:04","guid":{"rendered":"https:\/\/formulazdravlja.com\/?p=3631"},"modified":"2026-02-02T08:08:42","modified_gmt":"2026-02-02T07:08:42","slug":"kad-se-injekcija-zaustavi-zasto-se-kilaza-cesto-vraca-brze-nego-posle-neke-dijete","status":"publish","type":"post","link":"https:\/\/formulazdravlja.com\/en\/kad-se-injekcija-zaustavi-zasto-se-kilaza-cesto-vraca-brze-nego-posle-neke-dijete\/","title":{"rendered":"When the Injection Stops \u2013 Why Weight Often Comes Back Faster Than After a Typical Diet"},"content":{"rendered":"

GLP-1 medications (such as semaglutide and tirzepatide) have transformed obesity treatment: for many people, they lead to substantial weight loss and improvements in blood sugar, blood pressure, and blood lipids.
\u26a0\ufe0f But a large new evidence synthesis by researchers from the University of Oxford<\/a> highlights an uncomfortable reality: when the medication stops, the body often \u201cmoves back\u201d \u2014 and sometimes faster than after weight loss achieved through diet and exercise.<\/p>\n\n\n\n

\u2753 What did the study actually measure?<\/h5>\n\n\n\n

Researchers at the University of Oxford conducted a systematic review and meta-analysis (37 studies, 9,341 adults), tracking what happens after people discontinue weight-management medications.
\ud83d\udccc Average treatment duration was about 39 weeks, and follow-up after stopping was about 32 weeks.<\/p>\n\n\n\n

\ud83d\udcc9 How fast does weight return?<\/h5>\n\n\n\n

\u2705 On average, people regained about 0.4 kg per month after stopping treatment.
Based on these trends, the authors estimate that body weight could return to pre-treatment levels within about 1.5\u20132 years.<\/p>\n\n\n\n

\u26a0\ufe0f For newer, more potent therapies (semaglutide\/tirzepatide), the available data suggest weight regain could be even faster \u2014 around 0.8 kg per month \u2014 with the important note that data beyond 12 months are limited.<\/p>\n\n\n\n

\u2764\ufe0f What about the \u201chealth benefits\u201d \u2014 sugar, blood pressure, lipids?<\/h5>\n\n\n\n

During treatment, cardiometabolic markers (HbA1c, glucose, blood pressure, cholesterol, triglycerides) typically improve.
\u2757 However, the authors estimate that these markers also often trend back toward baseline \u2014 approximately within ~1.4 years after discontinuation.<\/p>\n\n\n\n

\u2753 Why is the rebound faster than after \u201cclassic\u201d lifestyle weight loss?<\/h5>\n\n\n\n

The meta-analysis suggests that weight regain after stopping medication was faster than after completing diet\/behavioral programs \u2014 by about 0.3 kg per month on average.<\/p>\n\n\n\n

\ud83e\udde0 A practical interpretation: with dietary change and physical activity, people often \u201ctrain\u201d maintenance skills and routines. With medication, weight loss may occur without the same maintenance training. After discontinuation (when appetite and hunger signals return), the system may lack new habits strong enough to hold the result.<\/p>\n\n\n\n

\ud83d\udccc Important: this is not \u201cthe drugs\u2019 fault\u201d \u2014 it\u2019s a reminder that obesity is often a chronic, relapsing condition<\/strong>, not a short-term problem with a quick fix.<\/p>\n\n\n\n

\u2705 What does this mean for patients (and anyone considering therapy)?<\/h5>\n\n\n\n
    \n
  1. \u2757 If you\u2019re using GLP-1 therapy, the plan should include \u201cwhat happens next.\u201d Not because the medication \u201cdoesn\u2019t work,\u201d but because the body has built-in rebound mechanisms.<\/li>\n\n\n\n
  2. \u26a0\ufe0f Don\u2019t stop therapy on your own. Discontinuation and transition planning are medical decisions and should be guided by a clinician.<\/li>\n\n\n\n
  3. \u2705 The best outcome is \u201cmedication + system.\u201d Medication can create a powerful window of opportunity to build habits that remain even if the dose changes or therapy ends.<\/li>\n<\/ol>\n\n\n\n
    \ud83d\udd0e Study limitations (to be fair)<\/h5>\n\n\n\n

    \ud83d\udccc The authors note that relatively few studies specifically tracked newer GLP-1 drugs, and post-cessation follow-up is often short (in some analyses up to 12 months), so some estimates rely partly on modeling.
    \u2705 Still, multiple analytical approaches pointed to similar conclusions.<\/p>\n\n\n\n

    Source: Sam West, Jadine Scragg, Paul Aveyard, Jason L Oke, Lia Willis, Stella J P Haffner, Heather Knight, Danni Wang, Sarah Morrow, Laura Heath, Susan A Jebb, Dimitrios A Koutoukidis.\u00a0Weight regain after cessation of medication for weight management: systematic review and meta-analysis.\u00a0BMJ, 2026; 392: e085304 DOI:\u00a010.1136\/bmj-2025-085304<\/a><\/em><\/p>\n\n\n\n

    \ud83d\udc9a\u00a0THE HEALTH FORMULA<\/a>\u00a0 \u2013 How to Increase the Chances Your Results Last<\/h5>\n\n\n\n

    These are the \u201cpillars\u201d that most often make the difference in long-term maintenance:<\/p>\n\n\n\n

    \ud83e\udd57 Protein + fiber first<\/strong> (satiety, muscle preservation, steadier glycemia)
    \ud83d\udcaa Strength training 2\u20133\u00d7 per week<\/strong> (muscle acts as a metabolic \u201cshock absorber\u201d after discontinuation)
    \ud83d\ude34\ud83e\udde0 Sleep and stress management<\/strong> (hunger and food choices are extremely sensitive to sleep loss and chronic stress)
    \ud83d\uddd3\ufe0f\ud83c\udfe0 Meal planning + environment design<\/strong> (what\u2019s at home, at work, and built into your routine)
    \ud83d\udcca Trend tracking<\/strong> (weight\/waist, glucose, lipids, blood pressure) \u2014 to react early, not after 8\u201310 kg comes back<\/p>\n\n\n\n

    \ud83d\ude42 It\u2019s \u201cboring,\u201d but it works \u2014 and that\u2019s exactly why many people skip it.
    \ud83d\ude80 Medication can be a strong \u201cstarter motor,\u201d but in the long run, the system wins.<\/p>","protected":false},"excerpt":{"rendered":"

    GLP-1 lekovi (poput semaglutida i tirzepatida) promenili su le\u010denje gojaznosti: kod mnogih ljudi donesu zna\u010dajan gubitak kilograma i pobolj\u0161aju \u0161e\u0107er, pritisak i masno\u0107e u krvi.\u26a0 Ali novo veliko pore\u0111enje studija istra\u017eiva\u010da sa Univerziteta Oxford upozorava na jednu neprijatnu realnost: kad terapija stane, telo \u010desto \u201ckrene nazad\u201d \u2013 i to br\u017ee nego posle mr\u0161avljenja nekom dijetom […]<\/p>\n","protected":false},"author":1,"featured_media":3633,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-3631","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health"],"blocksy_meta":[],"_links":{"self":[{"href":"https:\/\/formulazdravlja.com\/en\/wp-json\/wp\/v2\/posts\/3631","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/formulazdravlja.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/formulazdravlja.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/formulazdravlja.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/formulazdravlja.com\/en\/wp-json\/wp\/v2\/comments?post=3631"}],"version-history":[{"count":3,"href":"https:\/\/formulazdravlja.com\/en\/wp-json\/wp\/v2\/posts\/3631\/revisions"}],"predecessor-version":[{"id":3635,"href":"https:\/\/formulazdravlja.com\/en\/wp-json\/wp\/v2\/posts\/3631\/revisions\/3635"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/formulazdravlja.com\/en\/wp-json\/wp\/v2\/media\/3633"}],"wp:attachment":[{"href":"https:\/\/formulazdravlja.com\/en\/wp-json\/wp\/v2\/media?parent=3631"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/formulazdravlja.com\/en\/wp-json\/wp\/v2\/categories?post=3631"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/formulazdravlja.com\/en\/wp-json\/wp\/v2\/tags?post=3631"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}